Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
crispr
2
×
detroit blog main
detroit top stories
eli lilly
fda
glaxosmithkline
ipo
life sciences
national
national blog main
national top stories
new york blog main
2
×
new york top stories
2
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
acceleron pharma
acid sphingomyelinase deficiency
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
allergan
alzheimer's disease
andrew oxtoby
What
bio
moves
roundup
week
2
×
big
black
bosley's
bosley’s
bridge
bucks
cas
ceo
companies
continue
crime
crispr
debut
departure
diamond
diamond’s
editas
exit
guiding
indication
katrine
leading
life
mammoth
march
medicine
ohana’s
personnel
pop
science
steady
street
surprising
therapeutics
wall
Language
unset
Current search:
crispr
×
" new york blog main "
×
" new york top stories "
×
week
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More